CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $723,000 | -78.6% | 48,598 | +32.5% | 0.00% | -90.0% |
| Q3 2015 | $3,373,000 | +68.3% | 36,683 | +60.8% | 0.01% | +100.0% |
| Q2 2015 | $2,004,000 | +49.4% | 22,806 | +26.2% | 0.01% | +25.0% |
| Q1 2015 | $1,341,000 | +3.2% | 18,065 | -3.6% | 0.00% | -33.3% |
| Q1 2014 | $1,299,000 | +83.7% | 18,749 | +59.7% | 0.01% | +100.0% |
| Q4 2013 | $707,000 | +96.4% | 11,737 | +98.4% | 0.00% | +50.0% |
| Q3 2013 | $360,000 | +58.6% | 5,917 | +74.6% | 0.00% | +100.0% |
| Q2 2013 | $227,000 | – | 3,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |